TimLautenschlaegerMD

PubMed

• Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition.
  Amy Le, Homan Mohammadi, Toka Mohammed, Heather Burney, Yong Zang, Douglas Frye, Kevin Shiue, Tim Lautenschlaeger, James Miller> ;Journal of Neuro-Oncology. 2022 Jul 1
• 3 citations
  Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy.
  Susannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, Stuart A Grossman, Clemens Grassberger, Steven H Lin, Radhe Mohan> ;Advances in Radiation Oncology. 2022 Apr 8
• Discovery of increased number or interval growth of brain metastases on same-day GammaKnife™ planning MRI: Predicting factors and patient outcomes.
  Todd R Mereniuk, Heather N Burney, Tim Lautenschlaeger, Gordon A Watson, Ryan M Rhome> ;Journal of Radiosurgery and SBRT. 2022 Jan 1
• 3 citations
  Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer.
  Hong Zhang, Weili Wang, Pi Wenhu, Nan Bi, Colleen DesRosiers, Fengchong Kong, Monica Cheng, Li Yang, Tim Lautenschlaeger, Shruti Jolly, J.Y. Jin, Feng-Ming Spring Kong> ;Frontiers in Oncology. 2021 Jul 7
• Commentary: Postoperative Stereotactic Body Radiotherapy for Spinal Metastasis and Predictors of Local Control
  Kevin Shiue, James C Miller, Tim Lautenschlaeger, Stephanie K. Schaub, Simon S. Lo> ;Neurosurgery. 2021 May 13
• 15 citations
  Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
  Yongmei Liu, Weili Wang, Kevin Shiue, Huan Yao, Alberto Cerra-Franco, Ronald H. Shapiro, Ke Colin Huang, Douglas Vile, Mark Langer, Gordon A. Watson, Greg Bartlett, Hu...> ;Radiotherapy and Oncology. 2021 Mar 1
• 1 citations
  Feasibility of Performing Transvascular Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
  Rami Naaman, Tim Lautenschlaeger, Khalil Diab> ;Clinical Lung Cancer. 2021 Jan 7
• Reduced radiation necrosis in radiosurgical treatment of small brain metastases with 22 Gy.
  Shearwood McClelland, Todd R. Mereniuk, May Elbanna, Christina C. Huang, Tim Lautenschlaeger, James C Miller, Gordon A. Watson, R.M. Rhome> ;Journal of Radiosurgery and SBRT. 2021 Jan 1
• 3 citations
  Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
  Roshal R. Patel, Ethan B. Ludmir, Joseph A. Miccio, Hari Menon, Andrew R. Barsky, Shane Mesko, Manya Kodali, Tim Lautenschlaeger, Sebastian Adeberg, Charles B. Simone,...> ;Practical Radiation Oncology. 2020 Nov 1
• 1 citations
  Demographic factors associated with missed follow-up among solid tumor patients treated at a large multi-site academic institution.
  Samantha L. Freije, Jordan A. Holmes, Saleh Rachidi, Susannah G. Ellsworth, Richard C. Zellars, Tim Lautenschlaeger> ;Future Oncology. 2020 Sep 25
• 5 citations
  Radiosurgery dose reduction for brain metastases on immunotherapy (RADREMI): A prospective phase I study protocol.
  Shearwood McClelland, Tim Lautenschlaeger, Yong Zang, Nasser H. Hanna, Kevin Shiue, Aaron P. Kamer, Namita Agrawal, Susannah G. Ellsworth, R.M. Rhome, Gordon A. Watson> ;Reports of Practical Oncology and Radiotherapy. 2020 Apr 23
• Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
  May Elbanna, Kevin Shiue, Donna Edwards, Alberto Cerra-Franco, Namita Agrawal, J. Hinton, Todd R. Mereniuk, Christina C. Huang, Joshua L. Ryan, Jessica Smith, Vasantha...> ;Clinical Lung Cancer. 2021 May 1
• Exploiting tumor position differences between deep inspiration and expiration in lung stereotactic body radiation therapy planning
  Christina C. Huang, Kevin Shiue, Greg Bartlett, Namita Agrawal, Mona Arbab, P.G. Maxim, Colleen DesRosiers, Todd R. Mereniuk, Susannah G. Ellsworth, R.M. Rhome, Jordan...> ;Medical Dosimetry. 2020 Apr 2
• 5 citations
  Baseline Karnofsky performance status is independently predictive of death within 30 days of intracranial radiation therapy completion for metastatic disease.
  Shearwood McClelland, Namita Agrawal, May Elbanna, Kevin Shiue, G. Bartlett, Tim Lautenschlaeger, Richard C. Zellars, Gordon A. Watson, Susannah G. Ellsworth> ;Reports of Practical Oncology and Radiotherapy. 2020 Feb 24
• 1 citations
  First report of pulmonary large cell neuroendocrine carcinoma treated with stereotactic body radiation therapy.
  Shearwood McClelland, G. Durm, Thomas J. Birdas, Paul M. Musto, Tim Lautenschlaeger> ;Reports of Practical Oncology and Radiotherapy. 2019 Nov 1
• 2 citations
  Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
  Homan Mohammadi, Kevin Shiue, G. Daniel Grass, Vivek Verma, Kay Engellandt, Dirk Daubner, Gabriele Schackert, Mercia J Gondim, Dibson D. Gondim, Alexander O. Vortmeyer...> ;Neuro-Oncology Practice. 2019 Oct 10
• 1 citations
  The dosimetric differences in calculating lung SBRT plans on different image data sets: Comparison of the free breathing scan to both the average intensity projection ...
  Francesco Gaetani Liseo, T. Lautenschlaeger, Marvene Ewing, Mark Langer> ;Medical Dosimetry. 2019 Sep 1
• 2 citations
  Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
  Alberto Cerra-Franco, Sheng Liu, Michella Azar, Kevin Shiue, S. Freije, J. Hinton, Christopher R. Deig, Donna Edwards, Neil C. Estabrook, Susannah G. Ellsworth, Ke Hua...> ;Clinical Lung Cancer. 2019 May 1
• Platelet count correlates with stage and predicts survival in melanoma.
  Rachidi, S.,Kaur, M.,Lautenschlaeger, T.,Li, Z.> ;Platelets. 2019 Feb 14
• 13 citations
  Preoperative platelet counts and postoperative outcomes in cancer surgery: a multicenter, retrospective cohort study.
  Saleh Rachidi, Hong Li, Kristin Wallace, Zihai Li, Charles M. Balch, T. Lautenschlaeger> ;Platelets. 2020 Jan 2
• 44 citations
  TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas - a pilot prospective study
  Tareq A. Juratli, Sebastian Stasik, Amir Zolal, Caroline Schuster, Sven Richter, Dirk Daubner, Mazen A. Juratli, Rachel T. Thowe, Silke Hennig, Meriem Makina, Matthias...> ;Clinical Cancer Research. 2018 Nov 1
• 6 citations
  Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report.
  J. Hinton, Alberto Cerra-Franco, Kevin Shiue, Lindsey Shea, Vasantha Aaron, Geoffrey Billows, Ahmad Al-Hader, Tim Lautenschlaeger> ;Journal of Medical Case Reports. 2018 Oct 20
• 7 citations
  Toxicity of Radiosurgery for Brainstem Metastases
  Ajay Patel, Tuo Dong, Shaheryar F. Ansari, Aaron A. Cohen-Gadol, Gordon A. Watson, Fabio Y. Moraes, Masaki Nakamura, Judith A. Murovic, Steven D. Chang, Mustafa Aziz H...> ;World Neurosurgery. 2018 Nov 1
• 24 citations
  Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy
  Kevin Shiue, Alberto Cerra-Franco, Ronald H. Shapiro, Neil C. Estabrook, Edward M. Mannina, Christopher R. Deig, Sandra Althouse, Sheng Liu, Jun Wan, Yong Zang, Namita...> ;Journal of Thoracic Oncology. 2018 Oct 1
• 14 citations
  Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base.
  Vivek Verma, Adams Kusi Appiah, Tim Lautenschlaeger, Sebastian Adeberg, Charles B. Simone, Chi Lin> ;Journal of Gastrointestinal Oncology. 2018 Jun 1
• Join now to see all

Journal Articles

• TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas - a Pilot Prospective Study  
  Tim Lautenschlaeger, MD, Clinical Cancer Research